Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v5-FR | Version v1-EN |
|---|---|---|
| Language | French (Updated) | English |
| Date Updated | 2026-01-14 (Updated) | 2025-12-04 |
| Drug Identification Number | 02225271 | 02225271 |
| Brand name | BENZAMYCIN | BENZAMYCIN |
| Common or Proper name | BENZAMYCIN | BENZAMYCIN |
| Company Name | BAUSCH HEALTH, CANADA INC. | BAUSCH HEALTH, CANADA INC. |
| Ingredients | BENZOYL PEROXIDE ERYTHROMYCIN | BENZOYL PEROXIDE ERYTHROMYCIN |
| Strength(s) | 5% 3% | 5% 3% |
| Dosage form(s) | GEL | GEL |
| Route of administration | TOPICAL TOPICAL | TOPICAL TOPICAL |
| Packaging size | 46.6g | 46.6g |
| ATC code | D10AF | D10AF |
| ATC description | ANTI-ACNE PREPARATIONS FOR TOPICAL USE | ANTI-ACNE PREPARATIONS FOR TOPICAL USE |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2025-12-03 | 2025-12-03 |
| Estimated end date | 2026-01-31 | 2026-01-31 |
| Actual end date | 2026-01-13 (Updated) | |
| Shortage status | Resolved (Updated) | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Disruption of the manufacturing of the API | Disruption of the manufacturing of the API |
| Health Canada comments |